VUV Analytics announces Brian Smith to its Board after closing a $5.8M Series A equity round led by S3 Ventures

– USA, TX – VUV Analytics announced today that it closed a $5.8 million Series A equity investment to fund the launch of its laboratory-scale molecular spectroscopy instruments business.

The investment was led by S3 Ventures. In conjunction with the financing, S3’s Managing Director, Brian R. Smith, will join the company’s board of directors.

“We are really excited to close this investment with S3 Ventures,” said Sean Jameson, CEO of VUV Analytics. “They are the perfect fit and bring a tremendous wealth of knowledge regarding the business practices which are common among successful fast-paced technology companies. Their guidance and insight will be incredibly valuable to our business.”

VUV Analytics’ new vacuum ultraviolet (VUV) optical spectroscopy instruments exhibit unprecedented capabilities well beyond the state of the art in gas chromatography. The demonstrated benefits include affordable lower detection limits (in some cases enabling detection), significantly more information content for characterization purposes, and dramatic ease-of-use benefits over existing approaches.

“The added capability will allow us to rapidly expand the sales and marketing efforts supporting our first commercialized product,” added Jameson. “This instrument is expected to revolutionize the detection methods associated with gas chromatography, which is the most commonly used analytical technique in the world. Our technology will have a profound impact on the ease at which analytical chemists can do their jobs.” Brian R. Smith commented, “The team at VUV Analytics has a proven track record of bringing innovative technology to market. Their current product is poised for immediate and rapid growth. VUV’s core technology is unprecedented, and this presents an opportunity to become broadly applicable in multiple product offerings, serving numerous analytical laboratory market segments.”

VUV Analytics grew out of years of research in the vacuum ultraviolet spectrum. The five founders bring with them critical and unique know-how related to the hardware, software, analysis, intellectual property, and marketing associated with VUV technologies. The team’s past success in pioneering VUV reflectometry for use in the semiconductor metrology field yielded several key market wins and an extensive IP portfolio, including 28 issued and 12 pending patents.In August 2012, VUV Analytics announced that it was successfully selected as Texas Emerging Technology Fund recipient.

About S3 Ventures

S3 Ventures is an earlier stage venture firm with $170 million under management. The firm is focused on information technology solutions that solve large business problems and in medical devices that improve the human condition. S3 invests primarily in the formative stages of a company and partners with the team to help focus methodically on what it takes to build a successful company.

About Texas Emerging Technology Fund

The TETF is a $200 million initiative created by the Texas Legislature in 2005 at the governor’s request, and reauthorized in 2007, 2009, 2011 and 2013. A 17-member advisory committee of high-tech leaders, entrepreneurs and research experts reviews potential projects and recommends funding allocations to the governor, lieutenant governor and speaker of the house. To date, the TETF has allocated more than $205 million in funds to 144 early stage companies, and over $221 million in grant matching and research superiority funds to Texas universities. Additionally, since the inception of the TETF, more than $2.2 billion in additional investment from other non-state sources has followed on to the TETF investment, more than quadrupling the amount invested by the TETF.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.